Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Accenture
Moodys
Teva
Harvard Business School
Fuji
Healthtrust
UBS
McKinsey

Generated: September 20, 2018

DrugPatentWatch Database Preview

TOLMETIN SODIUM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tolmetin Sodium, and what generic alternatives are available?

Tolmetin Sodium is a drug marketed by Actavis Elizabeth, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Sun Pharm Industries, Teva, and G And W Labs Inc. and is included in fourteen NDAs.

The generic ingredient in TOLMETIN SODIUM is tolmetin sodium. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tolmetin sodium profile page.

Drug patent expirations by year for TOLMETIN SODIUM
Pharmacology for TOLMETIN SODIUM
Medical Subject Heading (MeSH) Categories for TOLMETIN SODIUM
Synonyms for TOLMETIN SODIUM
1-Methyl-5-(p-toluoyl)-2-pyrroleacetic acid
1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt
1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt, dihydrate
1H-Pyrrole-2-acetic acid, 1-methyl-5-(p-toluoyl)-, sodium salt
1H-Pyrrole-2-aceticacid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt (1:1)
26171-23-3 (Parent)
35711-34-3
AB01566945_01
AC-12807
ACM35711343
AK129821
AKOS015901707
AKOS015961034
API0016245
AX8154346
C02328
C15H14NO3.H2O.Na
C15H14NO3.Na
CCG-39123
CHEBI:9619
CHEMBL1200613
CTK4H5216
DTXSID2091546
EINECS 252-687-3
HE057302
HE329759
HMS1921E19
HMS2092O03
HMS500K15
I14-13943
KB-259743
KB-61756
LS-136617
LS-136619
McN-2559-21-98
NCGC00094796-01
NCGC00094796-02
QGUALMNFRILWRA-UHFFFAOYSA-M
SCHEMBL1477674
sodium [1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetate
Sodium 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetate
Sodium 2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetate
Sodium tolmetin
Sodium tolmetin dihydrate
SPECTRUM1500582
Toleclin
TOLECTIN 600
Tolectin DS
Tolmetin Sodium (anhydrous)
Tolmetin sodium [USAN:JAN]
Tolmetin sodium anhydrous
Tolmetin sodium salt
Tolmetin sodium salt dihydrate
Tolmetin Sodium, Anhydrous
UNII-WL259637KX
W-110866
WL259637KX

US Patents and Regulatory Information for TOLMETIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth TOLMETIN SODIUM tolmetin sodium CAPSULE;ORAL 073308-001 Jan 24, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva TOLMETIN SODIUM tolmetin sodium CAPSULE;ORAL 073519-001 May 29, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan TOLMETIN SODIUM tolmetin sodium CAPSULE;ORAL 073393-001 May 27, 1993 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs Inc TOLMETIN SODIUM tolmetin sodium TABLET;ORAL 074729-001 Feb 27, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Elizabeth TOLMETIN SODIUM tolmetin sodium TABLET;ORAL 073527-001 Jun 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Industries TOLMETIN SODIUM tolmetin sodium TABLET;ORAL 073310-001 Nov 27, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Accenture
Moodys
Teva
Harvard Business School
Fuji
Healthtrust
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.